# Tecan acquires ELISA kit assets from Cisbio Bioassays

Tecan Group agreed to acquire certain assets relating to four ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of Revvity. The asset purchase includes the manufacturing process of two IVD kits and two RUO kits.

- Type: Acquisition
- Announced: 2025-04-07
- Status: announced
- Products: ELISA immunoassay kits, IVD products, research-use-only kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tecan Group](https://endata.com/companies/55993.md) (acquirer)
- [Cisbio Bioassays SAS](https://endata.com/companies/83986.md) (target)
- [Revvity](https://endata.com/companies/83987.md) (partner)
- [IBL International GmbH](https://endata.com/companies/83988.md) (partner)

## Sources

- [news-medical.net](https://www.news-medical.net/news/20250407/Tecan-expands-portfolio-for-specialty-diagnostics-with-an-asset-purchase-relating-to-certain-ELISA-kits.aspx), 2025-04-07: "This strategic purchase aligns with our commitment to supporting customers with high-quality solutions while strengthening our portfolio in specialty diagnostics."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.